Non-deletional alpha thalassaemia: a review
Abstract Background Defective synthesis of the α-globin chain due to mutations in the alpha-globin genes and/or its regulatory elements leads to alpha thalassaemia syndrome. Complete deletion of the 4 alpha-globin genes results in the most severe phenotype known as haemoglobin Bart’s, which leads to...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01429-1 |
_version_ | 1818526675094208512 |
---|---|
author | Ibrahim Kalle Kwaifa Mei I. Lai Sabariah Md Noor |
author_facet | Ibrahim Kalle Kwaifa Mei I. Lai Sabariah Md Noor |
author_sort | Ibrahim Kalle Kwaifa |
collection | DOAJ |
description | Abstract Background Defective synthesis of the α-globin chain due to mutations in the alpha-globin genes and/or its regulatory elements leads to alpha thalassaemia syndrome. Complete deletion of the 4 alpha-globin genes results in the most severe phenotype known as haemoglobin Bart’s, which leads to intrauterine death. The presence of one functional alpha gene is associated with haemoglobin H disease, characterised by non-transfusion-dependent thalassaemia phenotype, while silent and carrier traits are mostly asymptomatic. Main body Clinical manifestations of non-deletional in alpha thalassaemia are varied and have more severe phenotype compared to deletional forms of alpha thalassaemia. Literature for the molecular mechanisms of common non-deletional alpha thalassaemia including therapeutic measures that are necessarily needed for the understanding of these disorders is still in demand. This manuscript would contribute to the better knowledge of how defective production of the α-globin chains due to mutations on the alpha-globin genes and/or the regulatory elements leads to alpha thalassaemia syndrome. Conclusion Since many molecular markers are associated with the globin gene expression and switching over during the developmental stages, there is a need for increased awareness, new-born and prenatal screening program, especially for countries with high migration impact, and for improving the monitoring of patients with α-thalassaemia. |
first_indexed | 2024-12-11T06:26:10Z |
format | Article |
id | doaj.art-c057a93b27b24f90b2d2112587225a37 |
institution | Directory Open Access Journal |
issn | 1750-1172 |
language | English |
last_indexed | 2024-12-11T06:26:10Z |
publishDate | 2020-06-01 |
publisher | BMC |
record_format | Article |
series | Orphanet Journal of Rare Diseases |
spelling | doaj.art-c057a93b27b24f90b2d2112587225a372022-12-22T01:17:40ZengBMCOrphanet Journal of Rare Diseases1750-11722020-06-0115111210.1186/s13023-020-01429-1Non-deletional alpha thalassaemia: a reviewIbrahim Kalle Kwaifa0Mei I. Lai1Sabariah Md Noor2Haematology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia (UPM)Haematology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia (UPM)Haematology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia (UPM)Abstract Background Defective synthesis of the α-globin chain due to mutations in the alpha-globin genes and/or its regulatory elements leads to alpha thalassaemia syndrome. Complete deletion of the 4 alpha-globin genes results in the most severe phenotype known as haemoglobin Bart’s, which leads to intrauterine death. The presence of one functional alpha gene is associated with haemoglobin H disease, characterised by non-transfusion-dependent thalassaemia phenotype, while silent and carrier traits are mostly asymptomatic. Main body Clinical manifestations of non-deletional in alpha thalassaemia are varied and have more severe phenotype compared to deletional forms of alpha thalassaemia. Literature for the molecular mechanisms of common non-deletional alpha thalassaemia including therapeutic measures that are necessarily needed for the understanding of these disorders is still in demand. This manuscript would contribute to the better knowledge of how defective production of the α-globin chains due to mutations on the alpha-globin genes and/or the regulatory elements leads to alpha thalassaemia syndrome. Conclusion Since many molecular markers are associated with the globin gene expression and switching over during the developmental stages, there is a need for increased awareness, new-born and prenatal screening program, especially for countries with high migration impact, and for improving the monitoring of patients with α-thalassaemia.http://link.springer.com/article/10.1186/s13023-020-01429-1α-ThalassaemiaMolecular basisNon-deletional mutationsGenotype-phenotype correlation |
spellingShingle | Ibrahim Kalle Kwaifa Mei I. Lai Sabariah Md Noor Non-deletional alpha thalassaemia: a review Orphanet Journal of Rare Diseases α-Thalassaemia Molecular basis Non-deletional mutations Genotype-phenotype correlation |
title | Non-deletional alpha thalassaemia: a review |
title_full | Non-deletional alpha thalassaemia: a review |
title_fullStr | Non-deletional alpha thalassaemia: a review |
title_full_unstemmed | Non-deletional alpha thalassaemia: a review |
title_short | Non-deletional alpha thalassaemia: a review |
title_sort | non deletional alpha thalassaemia a review |
topic | α-Thalassaemia Molecular basis Non-deletional mutations Genotype-phenotype correlation |
url | http://link.springer.com/article/10.1186/s13023-020-01429-1 |
work_keys_str_mv | AT ibrahimkallekwaifa nondeletionalalphathalassaemiaareview AT meiilai nondeletionalalphathalassaemiaareview AT sabariahmdnoor nondeletionalalphathalassaemiaareview |